Deferoxamine (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Deferoxamine drug offered from Fresenius Kabi USA, LLC. This Iron Chelating Activity [MoA],Iron Chelator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | DEFEROXAMINE MESYLATE |
| SUBSTANCE NAME: | DEFEROXAMINE MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Iron Chelating Activity [MoA],Iron Chelator [EPC] |
| ROUTE: | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2009-12-15 |
| END MARKETING DATE: | 0000-00-00 |
Deferoxamine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Deferoxamine from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 95(mg/mL) |
| START MARKETING DATE: | 2009-12-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-597_ec269364-6ff9-47df-b5ad-38922b2180d5 |
| PRODUCT NDC: | 63323-597 |
| APPLICATION NUMBER: | ANDA078718 |
Other DEFEROXAMINE MESYLATE Pharmaceutical Manufacturers / Labelers:
